Orbital Therapy of Bedford, MA, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ClearVue prone position breast radiotherapy treatment table.
Designed to simulate and treat breast cancer patients in the prone position, the carbon fiber add-on treatment table can be used with CT simulators and linear accelerators to plan and deliver radiation treatments.
Related Reading
Orbital Therapy debuts breast table, February 27, 2009
Copyright © 2009 Auninnie.com
